Hvsen Biotechnology Co., Ltd. (300871.SZ)
CNY 11.77
(-0.17%)
CNY 11.77
(-0.17%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 92.91 Million | 96.68 Million | 155.71 Million | 48.34 Million | 105.24 Million | 21.09 Million |
| Net Income | 16.78 Million | 52.7 Million | 132.86 Million | 150.15 Million | 68.76 Million | 71.4 Million |
| Depreciation & Amortization | 120.38 Million | 62.57 Million | 28.54 Million | 19.08 Million | 12.54 Million | 12.02 Million |
| Deferred income taxes | -10.29 Million | -4.91 Million | -2.2 Million | 897.21 Thousand | -6.12 Million | -2.06 Million |
| Stock-based compensation | - | -764.1 Thousand | 764.1 Thousand | - | - | - |
| Change in working capital | -76.19 Million | -31.1 Million | -18.89 Million | -130.33 Million | -2.3 Million | -77.64 Million |
| Other non-cash items | 28.84 Million | 12.5 Million | 13.21 Million | 9.45 Million | 26.23 Million | 15.31 Million |
| Investing Cash Flow | -100.3 Million | -749.54 Million | -185.14 Million | -670.43 Million | -122.94 Million | -34.01 Million |
| Investments in PPE | -184.31 Million | -428.86 Million | -600.12 Million | -230.84 Million | -123.05 Million | -34.05 Million |
| Acquisitions | - | 73.9 Thousand | 600.22 Million | 231.03 Million | 113.92 Thousand | 38.4 Thousand |
| Investment purchases | -985.52 Million | -1.02 Billion | -210 Million | -500 Million | - | - |
| Sales/Maturities of investments | 1.06 Billion | 699.24 Million | 624.87 Million | 60.21 Million | - | - |
| Other Investing Activities | 84 Million | 0.92 | -600.12 Million | -230.84 Million | 0.09 | 38.42 Thousand |
| Financing Cash Flow | -41.47 Million | -34.6 Million | 710.08 Million | 825.72 Million | 21.88 Million | 53.36 Million |
| Debt repayment | -33.45 Million | -135.2 Million | -61.69 Million | -119.9 Million | -36.1 Million | -28 Million |
| Dividends payments | -48.96 Million | -54.9 Million | -45.3 Million | -5.99 Million | -15 Million | -21.63 Million |
| Common Stock Repurchased | -3.3 Million | -53.67 Million | - | - | - | - |
| Common Stock Issuance | - | 53.67 Million | -4.62 Million | - | - | - |
| Other Financing Activities | 50.6 Million | 163.09 Million | 696.33 Million | 951.61 Million | 74.69 Million | 102.99 Million |
| Accounts receivables | -109.81 Million | 14.44 Million | 21.69 Million | -195.01 Million | -37.19 Million | -45.66 Million |
| Accounts payables | 71.98 Million | -71.04 Million | 67.53 Million | 119.6 Million | 32.16 Million | -5.09 Million |
| Inventory | -28.05 Million | 30.41 Million | -105.91 Million | -55.82 Million | 8.84 Million | -24.82 Million |
| Other working capital | 61.68 Million | -4.91 Million | -2.2 Million | 897.21 Thousand | -6.12 Million | -52.81 Million |
| Cash at beginning of period | 278.6 Million | 966.14 Million | 285.5 Million | 81.91 Million | 77.72 Million | 37.22 Million |
| Cash at end of period | 229.51 Million | 278.6 Million | 966.14 Million | 285.5 Million | 81.91 Million | 77.72 Million |
| Capital Expenditure | -184.31 Million | -428.86 Million | -600.12 Million | -230.84 Million | -123.05 Million | -34.05 Million |
| Effect of forex changes on cash | -232.82 Thousand | -70.08 Thousand | -27.49 Thousand | -37.06 Thousand | 4838.10 | 49 Thousand |
| Net cash flow / Change in cash | -49.09 Million | -687.53 Million | 680.63 Million | 203.59 Million | 4.18 Million | 40.49 Million |
| Free Cash Flow | -91.39 Million | -332.18 Million | -444.4 Million | -182.49 Million | -17.81 Million | -12.95 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 4.22 Million | -35.47 Million | -16.4 Million | 16.78 Million | 1.9 Million | -1.02 Million |
| Depreciation & Amortization | - | 27.68 Million | 27.68 Million | 120.38 Million | 33.21 Million | -54.03 Million |
| Deferred income taxes | - | - | - | -10.29 Million | - | - |
| Stock-based compensation | - | 1.86 Million | - | - | - | - |
| Change in working capital | - | -30.16 Million | - | -76.19 Million | -137.87 Million | 65.25 Million |
| Other non-cash items | 35.58 Million | 80.84 Million | -26.5 Million | 28.84 Million | 73.45 Million | 44.21 Million |
| Investing Cash Flow | -66.53 Million | 12.7 Million | -79.7 Million | -100.3 Million | 74.89 Million | -58.75 Million |
| Investments in PPE | -51.41 Million | -37.6 Million | -79.38 Million | -184.31 Million | -41.23 Million | -37.13 Million |
| Acquisitions | 387.44 Thousand | 310 Thousand | 80 Thousand | - | -1672.98 | 1672.98 |
| Investment purchases | -221.03 Million | -90 Million | -180.4 Million | -985.52 Million | -200.15 Million | -190 Million |
| Sales/Maturities of investments | 205.53 Million | 140 Million | 180 Million | 1.06 Billion | 316.28 Million | 168.37 Million |
| Other Investing Activities | - | 52.42 Million | 3.04 Million | 84 Million | 116.13 Million | 0.16 |
| Financing Cash Flow | -108.49 Million | 42.25 Million | 95.2 Million | -41.47 Million | -422.73 Thousand | -83.12 Million |
| Debt repayment | -113.28 Million | -53.65 Million | -80 Million | -33.45 Million | -6.54 Million | -97.36 Million |
| Dividends payments | -44.55 Million | -46.31 Million | -1.23 Million | -48.96 Million | -48.96 Million | -2.09 Million |
| Common Stock Repurchased | - | -2.39 Million | - | -3.3 Million | -3.3 Million | 3.3 Million |
| Common Stock Issuance | - | - | - | - | - | -3.3 Million |
| Other Financing Activities | -39.77 Million | 33.15 Million | 15.2 Million | 50.6 Million | -1.04 Million | 16.33 Million |
| Accounts receivables | - | 31.46 Million | - | -109.81 Million | -109.81 Million | 19.56 Million |
| Accounts payables | - | - | - | 71.98 Million | - | - |
| Inventory | - | -63.37 Million | - | -28.05 Million | -28.05 Million | 52.4 Million |
| Other working capital | - | 1.73 Million | - | - | - | -6.71 Million |
| Cash at beginning of period | 350.79 Million | 286.06 Million | 200.42 Million | 278.6 Million | 119.41 Million | 210.26 Million |
| Cash at end of period | 237.27 Million | 350.79 Million | 286.06 Million | 229.51 Million | 229.51 Million | 119.41 Million |
| Capital Expenditure | -51.41 Million | -37.6 Million | -79.38 Million | -184.31 Million | -41.23 Million | -37.13 Million |
| Effect of forex changes on cash | - | 41.55 Thousand | -355.52 Thousand | -232.82 Thousand | -232.98 Thousand | -12.4 Thousand |
| Net cash flow / Change in cash | -113.52 Million | 64.73 Million | 85.64 Million | -49.09 Million | 110.1 Million | -90.85 Million |
| Free Cash Flow | -11.61 Million | -19.91 Million | -122.28 Million | -91.39 Million | 909.63 Thousand | 17.28 Million |
002625
CSMG3
IFSH
NNCSF
5958
VIKRAMTH